Trade Summary

Yesterday, Loeillot Olivier, serving as CEO at Repligen Corp (RGEN), sold 3,832 shares at $140.00 per share, for a total transaction value of $536,480.00. Following this transaction, Loeillot Olivier now holds 54,246 shares of RGEN.

This sale represents a 7.00% decrease in Loeillot Olivier's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, April 21, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, April 22, 2026, 1 day after the trade was made.

Repligen Corp operates in the HEALTHCARE sector, specifically within the MEDICAL INSTRUMENTS & SUPPLIES industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.